Latest Security News

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.

Buru Energy reminds shareholders that its Share Purchase Plan closes on 7 October, offering shares at 2 cents each plus attaching options subject to approval.

Lefroy Exploration has received the first $1.25 million cash advance from BML Ventures, strengthening its financial position ahead of key development milestones at the Lucky Strike and Burns Central gold projects.

Lunnon Metals has reported promising drilling results at its Plentiful gold prospect, extending the mineralised structure to over 450 metres and revealing consistent widths and modest gold grades. These findings enhance the scale of opportunities within its Kambalda Gold & Nickel Project.

Aquirian Limited reports a 16.7% revenue increase alongside key operational advances at its Wubin facility and new leadership appointments, signaling strong momentum in mining services and technology.

TPC Consolidated and Wollar Solar Holding have agreed to extend key deadlines in their acquisition scheme as they await crucial FIRB approval, pushing the timeline into early 2026.

WestStar Industrial’s subsidiary SIMPEC has landed a $115 million contract to expand residue filtration capacity at Alcoa’s Pinjarra Alumina Refinery, marking a key growth milestone.

Southern Palladium has responded to an ASX price query denying undisclosed information behind its recent share price rise, instead pointing to positive commodity price trends and ongoing project developments.

RAM Essential Services Property Fund (REP) reports a Q1 FY26 distribution in line with guidance and reaffirms its full-year yield target while progressing its strategic transition to a healthcare-focused REIT.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.

Altamin Limited has initiated a 45 for 100 accelerated pro-rata entitlement offer at $0.025 per share to raise up to AUD 6.46 million, supporting its Lazio and Gorno projects in Italy. The offer includes a strong institutional backing and opens to eligible retail shareholders across multiple jurisdictions.